Cargando…
Lacosamide for refractory generalized tonic–clonic seizures of non-focal origin in clinical practice: A clinical and VEEG study
• 7 of 9 patients with GGE reduced ≥ 50% their tonic–clonic seizure frequency on LCM. • All 7 patients remained seizure free for > 1 year, and 2 of them for > 5 years. • In 2 of the 9 patients, both with Juvenile Absence Epilepsy, absences aggravated. • One aggravation consisted on a myoclonia...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5602820/ https://www.ncbi.nlm.nih.gov/pubmed/28948142 http://dx.doi.org/10.1016/j.ebcr.2017.08.001 |
_version_ | 1783264627472203776 |
---|---|
author | Abarrategui, Belén García-García, María Eugenia Toledano, Rafael Parejo-Carbonell, Beatriz Gil-Nagel, Antonio García-Morales, Irene |
author_facet | Abarrategui, Belén García-García, María Eugenia Toledano, Rafael Parejo-Carbonell, Beatriz Gil-Nagel, Antonio García-Morales, Irene |
author_sort | Abarrategui, Belén |
collection | PubMed |
description | • 7 of 9 patients with GGE reduced ≥ 50% their tonic–clonic seizure frequency on LCM. • All 7 patients remained seizure free for > 1 year, and 2 of them for > 5 years. • In 2 of the 9 patients, both with Juvenile Absence Epilepsy, absences aggravated. • One aggravation consisted on a myoclonia and absence status, in a patient with no history of myoclonia. • VEEG paralleled clinical improvement but didn't change in a case of absence worsening. |
format | Online Article Text |
id | pubmed-5602820 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-56028202017-09-25 Lacosamide for refractory generalized tonic–clonic seizures of non-focal origin in clinical practice: A clinical and VEEG study Abarrategui, Belén García-García, María Eugenia Toledano, Rafael Parejo-Carbonell, Beatriz Gil-Nagel, Antonio García-Morales, Irene Epilepsy Behav Case Rep Case Report • 7 of 9 patients with GGE reduced ≥ 50% their tonic–clonic seizure frequency on LCM. • All 7 patients remained seizure free for > 1 year, and 2 of them for > 5 years. • In 2 of the 9 patients, both with Juvenile Absence Epilepsy, absences aggravated. • One aggravation consisted on a myoclonia and absence status, in a patient with no history of myoclonia. • VEEG paralleled clinical improvement but didn't change in a case of absence worsening. Elsevier 2017-08-24 /pmc/articles/PMC5602820/ /pubmed/28948142 http://dx.doi.org/10.1016/j.ebcr.2017.08.001 Text en © 2017 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Case Report Abarrategui, Belén García-García, María Eugenia Toledano, Rafael Parejo-Carbonell, Beatriz Gil-Nagel, Antonio García-Morales, Irene Lacosamide for refractory generalized tonic–clonic seizures of non-focal origin in clinical practice: A clinical and VEEG study |
title | Lacosamide for refractory generalized tonic–clonic seizures of non-focal origin in clinical practice: A clinical and VEEG study |
title_full | Lacosamide for refractory generalized tonic–clonic seizures of non-focal origin in clinical practice: A clinical and VEEG study |
title_fullStr | Lacosamide for refractory generalized tonic–clonic seizures of non-focal origin in clinical practice: A clinical and VEEG study |
title_full_unstemmed | Lacosamide for refractory generalized tonic–clonic seizures of non-focal origin in clinical practice: A clinical and VEEG study |
title_short | Lacosamide for refractory generalized tonic–clonic seizures of non-focal origin in clinical practice: A clinical and VEEG study |
title_sort | lacosamide for refractory generalized tonic–clonic seizures of non-focal origin in clinical practice: a clinical and veeg study |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5602820/ https://www.ncbi.nlm.nih.gov/pubmed/28948142 http://dx.doi.org/10.1016/j.ebcr.2017.08.001 |
work_keys_str_mv | AT abarrateguibelen lacosamideforrefractorygeneralizedtonicclonicseizuresofnonfocalorigininclinicalpracticeaclinicalandveegstudy AT garciagarciamariaeugenia lacosamideforrefractorygeneralizedtonicclonicseizuresofnonfocalorigininclinicalpracticeaclinicalandveegstudy AT toledanorafael lacosamideforrefractorygeneralizedtonicclonicseizuresofnonfocalorigininclinicalpracticeaclinicalandveegstudy AT parejocarbonellbeatriz lacosamideforrefractorygeneralizedtonicclonicseizuresofnonfocalorigininclinicalpracticeaclinicalandveegstudy AT gilnagelantonio lacosamideforrefractorygeneralizedtonicclonicseizuresofnonfocalorigininclinicalpracticeaclinicalandveegstudy AT garciamoralesirene lacosamideforrefractorygeneralizedtonicclonicseizuresofnonfocalorigininclinicalpracticeaclinicalandveegstudy |